Tao Xie 37th Lorne Cancer Conference 2025

Abstracts this author is presenting:

• Development of PARP inhibitor-resistant ovarian cancer cell lines and discovery of a synergistic drug combination that increases sensitivity to PARP inhibition   — Poster Session II